StonvexLoading…
StonvexStonvexStonvexCore line items from INVZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $55.09M | $24.27M | $20.88M | $6.03M |
Operating Income | $-67.73M | $-101.92M | $-132.60M | $-133.35M |
Net Income | $-67.80M | $-94.76M | $-123.45M | $-126.87M |
EPS (Diluted) | $-0.34 | $-0.57 | $-0.84 | $-0.94 |
Total Assets | $138.45M | $132.05M | $219.23M | $255.43M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $8.64M | $25.36M | $26.28M | $55.72M |
Free Cash Flow OCF − CapEx | $-52.17M | $-81.37M | $-99.63M | $-115.98M |
Shares Outstanding | 214.09M | 169.40M | 165.39M | 136.19M |